A cell viability assay was conducted to investigate effect of RP with different radioisotopes. NCI-N87 cells overexpressing the HER2 protein were seeded at a density of 104 cells/well and incubated for 48 h after treatments. The cells were exposed to three types of drugs: trastuzumab, 177Lu-DOTA-trastuzumab, and 225Ac-DOTA-trastuzumab.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile